Supportive Listening with Depressed Low-Income mothers

描述（由申请人提供）：指导患者导向职业发展奖申请（K23）的最终重新提交，以支持Lisa Segre博士作为一名学术研究科学家的发展，她的专长是为低收入和少数民族妇女开发围产期抑郁症治疗。Segre博士打算通过正式课程获得额外的培训，在导师的监督下指导阅读，并与外部顾问团成员直接互动，同时追求一个研究项目，开发围产期抑郁症的新疗法。围产期抑郁症是一种严重的疾病，影响了大约13%的新妈妈，低收入和非裔美国妇女的风险尤其高。抑郁症对母亲抑郁的孩子的身体、社会情感和认知发展也有广泛而持久的影响。Segre博士的研究将集中在支持性倾听/问题解决（SUPS）的实施和后续评估上，SUPS是一种在英国已确立有效性的治疗方法。这种治疗由不具威胁性的专业人士提供，在家中进行，并传达一种重要的相互尊重的感觉。Segre博士打算引进、实施和评估这种治疗方法对低收入和少数民族女性抑郁症的有效性，这些女性不太可能、不愿意或无法从精神卫生专业人员那里寻求更传统的治疗方法。将特别强调使治疗适应美国心理健康和社会服务系统的背景，以及评估治疗的有效性。II期治疗评估试验的中心假设是：(1)支持性倾听/问题解决（SL/PS）在治疗结束和随访时显著比标准强化病例管理更有效地减轻抑郁症状，(2)在治疗结束和随访时显著比标准强化病例管理更有效地改善社会适应。(3)来访者和病例管理人员会发现SL/PS是一种可接受的治疗方法；(4)与参与标准的强化病例管理相比，参加SL/PS会显著增加专业心理健康服务的使用。

DESCRIPTION (provided by applicant): The final resubmission of a Mentored Patient-Oriented Career Development Award Application (K23) to support Dr. Lisa Segre's development as an academic research scientist with expertise in the development of perinatal depression treatments for low-income and ethnic minority women. Dr. Segre intends to obtain additional training through formal coursework, directed readings under supervision of her mentor, and direct interactions with members of her external advisory panel while pursuing a program of research to develop new treatments for perinatal depression. Perinatal depression is a serious disorder affecting approximately 13% of new mothers, with low-income and African-American women particularly at risk. Depression also has a pervasive and long-lasting impact on the physical, social-emotional, and cognitive development of children of depressed mothers. Dr. Segre's research will focus on the implementation and subsequent evaluation of supportive listening/problem solving (SUPS), a treatment with established effectiveness in the United Kingdom. This treatment is provided by non-threatening professionals, delivered in the home, and conveys an important sense of mutual respect. Dr. Segre intends to import, implement, and evaluate the effectiveness of this treatment for depressed low- income and ethnic minority women who are unlikely, unwilling, or unable to seek more traditional treatment from mental health professionals. A special emphasis will be placed on adapting the treatment to the context of the US mental health and social service system, as well as evaluating the treatment's effectiveness. The central hypotheses of the Phase II treatment evaluation trial are (1) that supportive listening/problem solving (SL/PS) will be significantly more effective than standard enhanced case management in reducing depressive symptoms at the end of treatment and follow-up, (2) SL/PS will be significantly more effective than standard enhanced case management in improving social adjustment at the end of treatment and follow-up, (3) clients and case managers will find SL/PS to be an acceptable treatment, and (4) participation in SL/PS will be associated with significantly more use of professional mental health services than participation in standard enhanced case management.